newsfilter
← Latest News
PR Newswire·

Elaris Secures Exclusive Global License from Valneva for C. difficile Vaccine Program

Elaris FlexCo ("Elaris"), an Austrian biotechnology company developing vaccines against serious bacterial infections, today announced an exclusive...